OpenURL Connection Search

Select item for more details and to access through your institution.

Correction to: Targeting of immune checkpoint regulator V-domain Ig suppressor of T-cell activation (VISTA) with <sup>89</sup>Zr-labelled CI-8993.
Published in:
2024
By:
- Burvenich, Ingrid Julienne Georgette;
- Wichmann, Christian Werner;
- McDonald, Alexander Franklin;
- Guo, Nancy;
- Rigopoulos, Angela;
- Huynh, Nhi;
- Vail, Mary;
- Allen, Stacey;
- O'Keefe, Graeme Joseph;
- Scott, Fiona Elizabeth;
- Soikes, Raul;
- Angelides, Steven;
- von Roemeling, Reinhard;
- Scott, Andrew Mark;
- Julienne, Ingrid;
- Burvenich, Georgette
Publication type:
Correction Notice
Targeting of immune checkpoint regulator V-domain Ig suppressor of T-cell activation (VISTA) with <sup>89</sup>Zr-labelled CI-8993.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 13, p. 3863, doi. 10.1007/s00259-024-06854-z
By:
- Burvenich, Ingrid Julienne Georgette;
- Wichmann, Christian Werner;
- McDonald, Alexander Franklin;
- Guo, Nancy;
- Rigopoulos, Angela;
- Huynh, Nhi;
- Vail, Mary;
- Allen, Stacey;
- O'Keefe, Graeme Joseph;
- Scott, Fiona Elizabeth;
- Soikes, Raul;
- Angelides, Steven;
- Roemeling, Reinhard von;
- Scott, Andrew Mark
Publication type:
Article
Fimepinostat (CUDC‐907) in patients with relapsed/refractory diffuse large B cell and high‐grade B‐cell lymphoma: report of a phase 2 trial and exploratory biomarker analyses.
Published in:
British Journal of Haematology, 2021, v. 195, n. 2, p. 201, doi. 10.1111/bjh.17730
By:
- Landsburg, Daniel J.;
- Barta, Stefan K.;
- Ramchandren, Radhakrishnan;
- Batlevi, Connie;
- Iyer, Swaminathan;
- Kelly, Kevin;
- Micallef, Ivana N.;
- Smith, Sonali M.;
- Stevens, Don A.;
- Alvarez, Mariano;
- Califano, Andrea;
- Shen, Yao;
- Bosker, Gideon;
- Parker, Jefferson;
- Soikes, Raul;
- Martinez, Elizabeth;
- von Roemeling, Reinhard;
- Martell, Robert E.;
- Oki, Yasuhiro
Publication type:
Article

Found: 3

Correction to: Targeting of immune checkpoint regulator V-domain Ig suppressor of T-cell activation (VISTA) with <sup>89</sup>Zr-labelled CI-8993.

Targeting of immune checkpoint regulator V-domain Ig suppressor of T-cell activation (VISTA) with <sup>89</sup>Zr-labelled CI-8993.

Fimepinostat (CUDC‐907) in patients with relapsed/refractory diffuse large B cell and high‐grade B‐cell lymphoma: report of a phase 2 trial and exploratory biomarker analyses.